Van Harten P N
Psychiatrisch Centrum Welterhof, Heerlen.
Ned Tijdschr Geneeskd. 1997 Jul 26;141(30):1471-4.
Acute dystonia is a side effect of antipsychotic medication; it nearly always develops a few weeks after the start of a dopamine-blocking agent or substantial increase of the dosage. Acute dystonia is characterized as a syndrome of sustained muscle contractions, frequently causing twisting and repetitive movements or abnormal postures. The risk of acute dystonia depends greatly on the presence of risk factors: early age, male sex, use of cocaine, a history of acute dystonia, and use of a highly potent antipsychotic agent in a normal dosage. The mechanism underlying acute dystonia is unknown: both increase and decrease of the striatal dopamine transmission have been put forward as possible causes. Acute dystonia may also be caused by dopamine-blocking agents that are used not as antipsychotic medication but, for instance, as anti-emetics. Anticholinergic agents are extremely efficacious in treatment as well as prevention of acute dystonia. Prophylaxis of acute dystonia is indicated for patients belonging to the risk groups.
急性肌张力障碍是抗精神病药物的一种副作用;几乎总是在开始使用多巴胺阻断剂或大幅增加剂量几周后出现。急性肌张力障碍的特征是持续的肌肉收缩综合征,常导致扭曲和重复性动作或异常姿势。急性肌张力障碍的风险在很大程度上取决于危险因素的存在:年龄小、男性、使用可卡因、有急性肌张力障碍病史以及正常剂量使用高效抗精神病药物。急性肌张力障碍的潜在机制尚不清楚:纹状体多巴胺传递的增加和减少都被提出作为可能的原因。急性肌张力障碍也可能由并非用作抗精神病药物的多巴胺阻断剂引起,例如用作止吐药时。抗胆碱能药物在治疗和预防急性肌张力障碍方面极其有效。对于属于风险组的患者,建议预防性使用抗胆碱能药物以预防急性肌张力障碍。